Following the launch of its Wegovy (semaglutide) pill at the beginning of the year, Novo Nordisk is committing as much as ...
Biologic therapy during pregnancy was not associated with adverse outcomes for most patients in a retrospective study presented at AAAAI 2026.
On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026. The Inflation Reduction Act (IRA), passed in August 2022, gives Medicare ...
The Nobel Prize in Medicine will never be awarded for excellence in the formulation and manufacture of biologic medicines. That’s understandable. Patients who need these medicines deserve the product ...
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...
Pharmaceutical Technology on MSN
NorthX Biologics and Demeetra collaborate on GMP manufacturing and CLD
The collaboration integrates Demeetra’s CleanCut CHO platforms and cell line services with NorthX Biologics’ GMP manufacturing expertise.
AbCellera Biologics (NASDAQ:ABCL) used its full-year 2025 business update call to emphasize that it has completed its ...
The data suggest significant challenges in maintaining long-term disease control with advanced systemic therapies for atopic dermatitis.
The Arvix BioMatrix™ platform is a modular biologic system comprising Base™, Core™, and Prime™ components designed to ...
Analysts are estimating that ADMA Biologics will report an earnings per share (EPS) of $0.20. Investors in ADMA Biologics are eagerly awaiting the company's announcement, hoping for news of surpassing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results